
Alexander Light
@ajwlight
NIHR Doctoral Fellow @IP_London @NIHRresearch | Urology registrar @NorthLonUrol | 🇬🇧🇲🇾🇨🇳
ID: 940260948106993664
https://www.imperial.ac.uk/people/a.light 11-12-2017 16:44:14
2,2K Tweet
2,2K Followers
3,3K Following


It’s a busy #ProstateCancer session at #BAUS25 - kicking off is Martin J. Connor with the outcomes from the #IP2ATLANTA pilot study 📊



Nikhil Mayor presents outcomes from the first prospective, blinded assessment of #FCM with the #HistologScanner in #RadicalProstatectomy #IP8FLUORESCE


Wrapping up the session is Deepika Reddy with the outcomes of 1379 men undergoing #FocalTherapy with #HIFU 🦾



A superb turnout for our #BAUS25 Fun Run in collaboration with TheUrologyFoundation Massive 👏 to our volunteers and especially Sophie R-H for her wonderful organisation, as per usual. Managed to avoid losing anyone en route, we think… BAUS


Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by Taimur Shah Key takeaways - MRI highly sensitive for local disease (even more so with PSMA PET/CT) & focal therapy as effective as RP in the salvage setting #BAUS25


Meanwhile! Back at in London, Fran Rawlins gave a brilliant presentation showcasing TRANSFORM at the ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening Surgery and Cancer Prostate Cancer UK Hashim U. Ahmed


[4/8] 🦆The TRANSFORM team Nikhil Mayor Fran Rawlins Alexander Light Dr Phil McNamee Imperial Prostate Social Psychiatry helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer. 🔗prostatecanceruk.org/research/trans…
![ProstateUK Profs (@prostateukprofs) on Twitter photo [4/8]
🦆The TRANSFORM team <a href="/NikhilMayor/">Nikhil Mayor</a> <a href="/Fran_Rawlins/">Fran Rawlins</a> <a href="/AJWLight/">Alexander Light</a> <a href="/philipmcnamee/">Dr Phil McNamee</a> <a href="/IP_London/">Imperial Prostate</a> <a href="/QMULSocialPsych/">Social Psychiatry</a> helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer.
🔗prostatecanceruk.org/research/trans… [4/8]
🦆The TRANSFORM team <a href="/NikhilMayor/">Nikhil Mayor</a> <a href="/Fran_Rawlins/">Fran Rawlins</a> <a href="/AJWLight/">Alexander Light</a> <a href="/philipmcnamee/">Dr Phil McNamee</a> <a href="/IP_London/">Imperial Prostate</a> <a href="/QMULSocialPsych/">Social Psychiatry</a> helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer.
🔗prostatecanceruk.org/research/trans…](https://pbs.twimg.com/media/Gttsw-7WoAAhkGA.jpg)

Finishing up #BAUS25 on the main stage our Clinical Lecturer Martin J. Connor presenting an update on two major UK prostate randomised controlled trial published this year #TRANSLATE #NEUROSAFE


Congratulations to the #IP2ATLANTA trials team on their presentation being selected for best of #BAUS25 Hashim U. Ahmed Martin J. Connor


Hashim U. Ahmed Shonit Punwani Anwar Padhani European Urology Learn more about the team of researchers leading TRANSFORM, the Prostate Cancer UK-funded £42 million trial to find the best way to screen for #ProstateCancer 🔗prostatecanceruk.org/research/for-r…


Great to see our PhD student Nikhil Mayor present the #TRANSFORM trial at tonight’s European Association of Urology (EAU) UROwebinar: The role of MRI in prostate cancer screening and diagnosis Recruitment to start later this year! Hashim U. Ahmed Prostate Cancer UK


Great news! The IP7-PACIFIC Protocol paper has been published 😍 take a look... 👀 sciencedirect.com/science/articl… Imperial Prostate Jon Aning NBT_BUI Research at North Bristol NHS Trust Rebecca Cousins Marta Cobos-Arrivabene

The protocol paper for the #IP7PACIFIC RCT is now available online! This trial led by our group and funded by Cancer Research UK will provide definitive evidence for "fast" biparametric MRI and image-fusion biopsy using a novel trial design 🚨 Nikhil Mayor sciencedirect.com/science/articl…


🚨What's in a name? Why differentiation between biochemical recurrence and metastatic #prostatecancer matters 👏 New review led by Anael Rizzo David Geffen School of Medicine at UCLA & Pratik Kanabur UCLA Urology 👉Differentiating BCR & metastatic risk groups is 🔑 to help personalize care for our patients




Great to see one of our Chairs of Urology Heer Lab on the cover of the latest Urology Matters TheUrologyFoundation! Discussions about #TRANSFORM, his research programme at Imperial College London and role as Chair of the Scientific and Education Committee at TheUrologyFoundation
